News
OHE Welcomes David Parkin as a Visiting Researcher
2 April 2013
OHE is delighted to welcome Prof David Parkin as a visiting researcher at OHE over the coming months. A long-standing member of the EuroQol Group, Prof…
OHE Presents at Two Key Workshops on Use of EQ-5D in HTA Across Asia
27 March 2013
OHE’s Prof Nancy Devlin presented at two key workshops held for researchers and HTA policy makers from across Asia. The workshops were organised by Prof Nan…
The Economics of the Market for Medicines: 2013 Review
26 March 2013
OHE’s Dr Jorge Mestre-Ferrandiz is a visiting lecturer in the Department of Economics at City University London. As part of his 2013 activities, he recently gave…
Realising the Value of Medical Research: Health and Economic Benefits
20 March 2013
OHE’s Jon Sussex is spoke today on the value of medical research at the 2013 BioWales conference, one of the UK’s largest life sciences conferences. Celebrating…
OHE This Week: BioWales 2013, UK Medicines Market and EQ-5D in Asia
18 March 2013
19 March: Jon Sussex will be at BioWales 2013 speaking on the health and wider economic benefits of life sciences research. 21 March: Jorge Mestre-Ferrandiz will…
OHE has a Fixed-Term Opening for an Economist
15 March 2013
OHE is recruiting a highly motivated, experienced and energetic economist on a fixed term contract to contribute to its core activities. Applications must be received by…
Reasons for Discontinuation of R&D Projects: Lead and Follow-on Indications
12 March 2013
The reasons for discontinuation of R&D projects in the biopharmaceutical industry are often a matter of conjecture. In a recent presentation to the 25th Annual EuroMeeting…
Does Free Personal Care for the Elderly Reduce Informal Caregiving?
25 February 2013
Debates about whether to increase state assistance to the elderly have included concerns that this could reduce the amount of care from such personal caregivers, producing…
Review of Plans for Refining Patient-Reported Outcomes Measures
19 February 2013
At a recent meeting of the Pharmaceutical Onology Initiative’s (POI) HTA group, OHE’s Nancy Devlin provided an overview of the EuroQol Group’s scientific research agenda for…